Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

629

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
COPD
Interventions
DRUG

QMF149

delivered via Concept1 device

DRUG

Salmeterol

delivered via Accuhaler®

Trial Locations (115)

1000

Novartis Investigative Site, Brussels

1036

Novartis Investigative Site, Budapest

1233

Novartis Investigative Site, Sofia

1234

Novartis Investigative Site, Sofia

1431

Novartis Investigative Site, Sofia

2057

Novartis Investigative Site, Johannesburg

2139

Novartis Investigative Site, Concord

2217

Novartis Investigative Site, Kogarah

2305

Novartis Investigative Site, New Lambton Heights

2660

Novartis Investigative Site, Balasagyarmat

3065

Novartis Investigative Site, Fitzroy

3128

Novartis Investigative Site, Box Hill

3199

Novartis Investigative Site, Franston

3545

Novartis Investigative Site, Halen

4000

Novartis Investigative Site, Liège

4001

Novartis Investigative Site, Durban

4020

Novartis Investigative Site, Redcliffe

4170

Novartis Investigative Site, eMkhomazi

4400

Novartis Investigative Site, Nyíregyháza

5000

Novartis Investigative Site, Veliko Tarnovo

5011

Novartis Investigative Site, Woodville South

5041

Novartis Investigative Site, Daw Park

5042

Novartis Investigative Site, Bedford Park

5540

Novartis Investigative Site, Szarvas

5800

Novartis Investigative Site, Pleven

6000

Novartis Investigative Site, Stara Zagora

6009

Novartis Investigative Site, Nedlands

7002

Novartis Investigative Site, Rousse

7500

Novartis Investigative Site, Cape Town

7505

Novartis Investigative Site, Cape Town

7531

Novartis Investigative Site, Cape Town

7633

Novartis Investigative Site, Pécs

7764

Novartis Investigative Site, Cape Town

7925

Novartis Investigative Site, Cape Town

8200

Novartis Investigative Site, Veszprém

8582

Novartis Investigative Site, Farkasgyepű

8600

Novartis Investigative Site, Siófok

9010

Novartis Investigative Site, Varna

9301

Novartis Investigative Site, Bloemfontein

9330

Novartis Investigative Site, Kapuvár

10400

Novartis Investigative Site, Bangkok

10676

Novartis Investigative Site, Athens - GR

10700

Novartis Investigative Site, Bangkok

10969

Novartis Investigative Site, Berlin

11000

Novartis Investigative Site, Taladkwan

11527

Novartis Investigative Site, Athens

12203

Novartis Investigative Site, Berlin

15562

Novartis Investigative Site, Rüdersdorf

21152

Novartis Investigative Site, Malmo

22927

Novartis Investigative Site, Großhansdorf

23552

Novartis Investigative Site, Lübeck

26120

Novartis Investigative Site, Nakhon Naiyok

30167

Novartis Investigative Site, Hanover

34000

Novartis Investigative Site, Taiping

34362

Novartis Investigative Site, Haifa

40002

Novartis Investigative Site, Muang

44281

Novartis Investigative Site, Kfar Saba

46015

Novartis Investigative Site, Valencia

49100

Novartis Investigative Site, Petah Tikva

50159

Novartis Investigative Site, Bucharest

58452

Novartis Investigative Site, Witten

59100

Novartis Investigative Site, Kuala Lumpur

60596

Novartis Investigative Site, Frankfurt

64239

Novartis Investigative Site, Tel Aviv

65187

Novartis Investigative Site, Wiesbaden

68100

Novartis Investigative Site, Batu Caves

76100

Novartis Investigative Site, Rehovot

78278

Novartis Investigative Site, Ashkelon

90110

Novartis Investigative Site, Songkhla

91031

Novartis Investigative Site, Jerusalem

91120

Novartis Investigative Site, Jerusalem

93093

Novartis Investigative Site, Donaustauf

119074

Novartis Investigative Site, Singapore

169608

Novartis Investigative Site, Singapore

400162

Novartis Investigative Site, Cluj-Napoca

400371

Novartis Investigative Site, Cluj-Napoca

540136

Novartis Investigative Site, Târgu Mureş

900002

Novartis Investigative Site, Constanța

DK-2900

Novartis Investigative Site, Hellerup

DK-2650

Novartis Investigative Site, Hvidovre

DK-2400

Novartis Investigative Site, Copenhagen NV

DK-5000

Novartis Investigative Site, Odense C

FIN-20100

Novartis Investigative Site, Turku

FIN-28500

Novartis Investigative Site, Pori

FIN-33521

Novartis Investigative Site, Tampere

GR-71110

Novartis Investigative Site, Heraklion Crete

GR 115 27

Novartis Investigative Site, Athens

GR 41110

Novartis Investigative Site, Larissa

GR 56403

Novartis Investigative Site, Thessaloniki

GR 570 10

Novartis Investigative Site, Thessaloniki

GR-106 76

Novartis Investigative Site, Athens

Unknown

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, New Territories

H-9401

Novartis Investigative Site, Sopron

80-211

Novartis Investigative Site, Gdansk

15-010

Novartis Investigative Site, Bialystok

15-270

Novartis Investigative Site, Bialystok

15-461

Novartis Investigative Site, Bialystok

14-200

Novartis Investigative Site, Iława

40-752

Novartis Investigative Site, Katowice

90-153

Novartis Investigative Site, Lodz

63-400

Novartis Investigative Site, Ostrów Wielkopolski

64-920

Novartis Investigative Site, Piła

60-569

Novartis Investigative Site, Poznan

71-124

Novartis Investigative Site, Szczecin

33-100

Novartis Investigative Site, Tarnów

50-434

Novartis Investigative Site, Wroclaw

020125

Novartis Investigative Site, Bucharest

07120

Novartis Investigative Site, Palma de Mallorca

08025

Novartis Investigative Site, Barcelona

08035

Novartis Investigative Site, Barcelona

405 30

Novartis Investigative Site, Gothenburg

412 63

Novartis Investigative Site, Gothenburg

SE-221 85

Novartis Investigative Site, Lund

162 68

Novartis Investigative Site, Vällingby

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY